Literature DB >> 6435706

Influence of protein-calorie malnutrition on the pharmacokinetics, placental transfer and tissue localization of dexamethasone in rats.

D R Varma, T L Yue.   

Abstract

The influence of protein-calorie malnutrition (PCM) on the pharmacokinetics, transplacental passage and tissue localization of dexamethasone was determined in Sprague-Dawley rats. PCM increased the plasma half-life and volume of distribution of dexamethasone in pregnant but not in nonpregnant rats. Ratios of foetal to maternal serum dexamethasone concentrations were 0.2-0.4 at different dose levels (0.8-20 mumol kg-1), time intervals (0.25-12 h) and gestational ages (day 14-21). PCM increased the foetal serum and tissue concentrations of dexamethasone but exerted no significant effect on its binding to maternal and foetal serum proteins or on its metabolism by the placenta. It is suggested that significantly lower foetal than maternal serum levels of dexamethasone are due to efficient elimination of this agent by the foeto-placental unit and an impairment of this mechanism may account for the observed increase in dexamethasone levels in the foetuses of PCM rats.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435706      PMCID: PMC1987194          DOI: 10.1111/j.1476-5381.1984.tb10127.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Pharmacological approaches to the acceleration of fetal lung matturation.

Authors:  M E Avery
Journal:  Br Med Bull       Date:  1975-01       Impact factor: 4.291

2.  The transplacental passage of prednisone and prednisolone in pregnancy near term.

Authors:  I Z Beitins; F Bayard; I G Ances; A Kowarski; C J Migeon
Journal:  J Pediatr       Date:  1972-11       Impact factor: 4.406

3.  Placental transfer of dexamethasone in near-term sheep.

Authors:  D F Anderson; M K Stock; J H Rankin
Journal:  J Dev Physiol       Date:  1979-12

4.  In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta.

Authors:  A T Blanford; B E Murphy
Journal:  Am J Obstet Gynecol       Date:  1977-02-01       Impact factor: 8.661

Review 5.  Pharmacokinetics in the ovine maternal-fetal unit.

Authors:  H H Szeto
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

6.  Distribution of dexamethasone between mother and fetus after maternal administration.

Authors:  J D Funkhouser; K J Peevy; P B Mockridge; E R Hughes
Journal:  Pediatr Res       Date:  1978-11       Impact factor: 3.756

7.  Drug disposition and pharmacokinetics in the maternal-placental-fetal unit.

Authors:  B Krauer; F Krauer; F E Hytten
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

8.  Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome.

Authors:  P L Ballard; P Granberg; R A Ballard
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Anti-inflammatory and ulcerogenic effects and pharmacokinetics of dexamethasone in protein-deficient rats.

Authors:  D R Varma; S Mulay
Journal:  J Pharmacol Exp Ther       Date:  1980-07       Impact factor: 4.030

10.  Comparison of the transplacental pharmacokinetics of cortisol and triamcinolone acetonide in the rhesus monkey.

Authors:  W Slikker; Z R Althaus; J M Rowland; D E Hill; A G Hendrickx
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

View more
  9 in total

1.  Stability of dexamethasone sodium phosphate in rat plasma.

Authors:  Mahesh N Samtani; William J Jusko
Journal:  Int J Pharm       Date:  2005-09-14       Impact factor: 5.875

2.  Nonspecific action of glucocorticosteroids after high-dose pulse therapy?

Authors:  R Hirschelmann; R Schade; W Bürger; H Bekemeier
Journal:  Agents Actions       Date:  1990-08

3.  A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats.

Authors:  Liang Li; Zai-quan Li; Chen-hui Deng; Miao-ran Ning; Han-qing Li; Shan-shan Bi; Tian-yan Zhou; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

4.  Investigation of the maternal to foetal serum concentration gradient of dexamethasone in the rat.

Authors:  D R Varma
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

5.  Comparison of dexamethasone pharmacokinetics in female rats after intravenous and intramuscular administration.

Authors:  Mahesh N Samtani; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2005-04       Impact factor: 1.627

6.  [Influence of dexamethasone on the cell polarity and PAR complex of the embryonic epithelial cells in the palate].

Authors:  Ma Li; Shi Bing; Zheng Qian
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-02-01

7.  In vivo pharmacokinetic study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery.

Authors:  C S Leopold; D R Friend
Journal:  J Pharmacokinet Biopharm       Date:  1995-08

8.  Area/moment and compartmental modeling of pharmacokinetics during pregnancy: applications to maternal/fetal exposures to corticosteroids in sheep and rats.

Authors:  Mahesh N Samtani; Matthias Schwab; Peter W Nathanielsz; William J Jusko
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

9.  Influence of streptozotocin-diabetes on the pharmacokinetics, placental transfer and tissue localization of dexamethasone in rats.

Authors:  S Mulay; D R Varma
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.